Novo Nordisk speaking at Lyophilisation 2014 share insight on PAT implementation

Dr Sune Klint Andersen, Principal Scientist, Novo Nordisk share their experience with PAT implementation in pharmaceutical spray drying at SMi's second annual Lyophilisation: Pharmaceuticals and Biopharmaceuticals Conference, 7-8 July, London, UK.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend

2nd Annual Lyophilisation 2014

the challenge may at first appear daunting, but it is one that must be met if the compounds being developed are to be successful.

London, Southwark (PRWEB UK) 12 April 2014

Lyophilisation is one of the most effective ways of giving to biotechnologically produced drugs greater stability and a longer shelf-life, while still maintaining their effectiveness. For drug manufacturers, the challenge may at first appear daunting, but it is one that must be met if the compounds being developed are to be successful. (Source: International Pharmaceutical Industry (IPI), Developing a Lyophilised Portfolio, 2014)

Novo Nordisk will be speaking at this years' Lyophilisation Conference to provide practical considerations in implementation of PAT, as well as providing case studies on PAT applicability in a small scale spray dryer, and the implementation/ results in a production scale spray dryer.

This years' event will provide an update on advances within lyophilisation. It will examine the latest techniques and industry case studies to manage your lyophilisation cycle effectively. With a workshop and sessions led by experts, you will gain an array of tools and tips to deliver the best outcome for your organisation.

We have a plethora of high calibre technical presentations that comprise:

  • Advancements in Lyophilised drug product development and scale-up from MedImmune;
  • Essentials in freeze-drying from Boehringer Ingelheim.
To download a brochure, visit http://www.lyophilisation-conference.com.

Some of the confirmed attendees so far include: Boehringer Ingelheim, Allembis, Explicat Pharma, MedImmune, Novo Nordisk, GlaxoSmithKline, Genzyme, Alexion Pharmaceuticals, Ellab, Ipsen, Ghent University, GEA Pharma Systems, GEA Process Engineering, Bavarian Nordic, Imperial College London, Newcastle University, plus many more.

Lyophilisation 2014: Pharmaceuticals & Biopharmaceuticals
7-8 July, 2014
Marriott Regents Park Hotel, London, UK
http://www.lyophilisation-conference.com

About SMi Group

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.

We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

More information can be found at http://www.smi-online.co.uk.


Contact